Stay updated on EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial
Sign up to get notified when there's something new on the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page.

Latest updates to the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision indicator was updated from v3.6.3 to v3.6.4, representing a minor administrative update to the page environment without altering the study information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows a new site revision tag (v3.6.3), replacing the previous v3.6.0, indicating a minor UI/backend update to the page.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now indicates that enrollment is closed ('No longer looking for participants'), and updates include added sections/links (How to Read a Study Record, Common Questions, How to Join a Study) with a standardized Intervention/Treatment header and a revision bump to v3.6.0, replacing the old Intervention / Treatment header.SummaryDifference0.4%

- Check58 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, representing a small update to the record. No substantive content changes are indicated.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page footer/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site software/version change rather than a change to the clinical trial record.SummaryDifference0.1%

Stay in the know with updates to EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page.